[Antagonizing thrombolytic therapy].
Spannagl
M
M
Klinikum, Universität München, Innenstadt. mispannagl@t-online.de
D000933:Antifibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007611:Aprotinin / Q000008:administration & dosage / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000009:adverse effects* / Q000494:pharmacology*; D006801:Humans; D007431:Intraoperative Complications / Q000097:blood* / Q000517:prevention & control; D014361:Trypsin Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use
D000933:Antifibrinolytic Agents; D005343:Fibrinolytic Agents; D014361:Trypsin Inhibitors; D007611:Aprotinin